Does management of lipid lowering differ between specialists and primary care: Insights from GOAL Canada.

Anatoly LangerMary TanShaun G GoodmanJean GrégoirePeter J LinG B John ManciniJames A StoneLawrence A Leiter

Published in: International journal of clinical practice (2020)

Despite minor differences in the clinical profile of their patients, both PCPs and specialists actively participate in the management of lipid-lowering therapy in high-risk CVD patients and experience similar challenges and care gaps.

Keyphrases

primary care
end stage renal disease
ejection fraction
newly diagnosed
healthcare
prognostic factors
fatty acid
mesenchymal stem cells
chronic pain
pain management
quality improvement
affordable care act